Stemolecule™ CD437
This product has been discontinued.
Product Overview
CD437 is a retinoic acid receptor gamma (RARγ)-selective retinoid agonist shown to effectively inhibit growth and induce apoptosis of a variety of cancer cells1. Two forms of dose-dependent action have been reported for this molecule. One mechanism enables induction of apoptosis by a receptor-independent pathway and the other is regulated by a receptor-dependent pathway and is shown to suppress cell differentiation2. More recently, Liu, et al. demonstrated the significance of retinoic acid (RA) signaling in reprogramming somatic cells to induced pluripotent stem (iPS) cells. Treatment of mouse embryonic fibroblasts (MEFs) with CD437 early in the reprogramming process significantly increases reprogramming efficiency up to 20 fold3. This suggests promoting RA signaling with CD437 may have important implications in reprogramming to a ground-state pluripotency (naïve stem cells).
Product Specifications
Size
5 mg
Alternate Name
6-[3-(adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid
Chemical Formula
C27H26O3
Molecular Weight
398.49
CAS Number
125316-60-1
Purity
Greater than 95% by HPLC analysis
Formulation
White crystalline solid
Solubility
For a 10 mM concentrated stock solution of CD437, reconstitute the compound by adding 1.25 ml of DMSO to the entire contents of the vial. If precipitate is observed, warm the solution to 37°C for 2 to 5 minutes. For cell culture, the media should be prewarmed prior to adding the reconstituted compound. Note: for most cells, the maximum tolerance to DMSO is less than 0.5%. This molecule is soluble in DMSO at 100 mM.
Storage and Stability
Store powder at either 4°C or -20°C, protected from light. Following reconstitution, store aliquots at -20°C. Stock solutions are stable for 6 months when stored as directed.
Quality Control
The purity of CD437 was determined by HPLC analysis. The accurate mass was determined by mass spectrometry. Cellular toxicity of CD437 was tested on mouse embryonic stem cells.
Related Products
- All-Trans Retinoic Acid (04-0021)
- ec23 (SRP002)
References
- Li, Y., Lin, B., Agadir, A., Liu, R., Dawson, M.I., Reed, J.C., Fontana, J.A., Bost, F., Hobbs, P.D., Zheng, Y., Chen, G.Q., Shroot, B., Mercola, D., and Zhang, X.K. (1998) Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol Cell Biol. 18: 4719-4731.
- Sun, S.Y., Yue, P., Chandraratna, R.A., Tesfaigzi, Y., Hong, W.K., and Lotan, R. (2000) Dual mechanisms of action of the retinoid CD437: nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells. Mol Pharmacol 58: 508-514.
- Wang, W., Yang, J., Liu, H., Lu, D., Chen, X., Zenonos, Z., Campos, L.S., Rad, R., Guo, G., Zhang, S., Bradley, A., and Liu, P. (2011) Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci USA 108: 18283-18288.
Stemgent Comments and Reviews (0)
No comments or reviews yet. Be the first to leave a review.
Add a Comment
You must log-in or register as a Stemgent member to submit a comment.
You are fully responsible for the content you post. We encourage collaboration and helpful reviews among scientists and will use this feature to conduct helpful reviews of our products. Content that includes profanity, personal attacks or antisocial behavior (such as "spamming" or "trolling"), or other inappropriate content or material will be removed. We reserve the right to block any user who violates our terms of use, including removing all content posted by that user.